Finnish Luxury Stock News

Danish authorities have opened a new police investigation into Nordea Finans Danmark regarding potential breaches of the Money Laundering Act. The case follows the Danish FSA's inspection, which highlighted systematic weaknesses in customer due diligence processes. Nordea disputes both the findings and the proportionality of the proposed administrative fine. The police investigation puts fresh regulatory pressure on Nordea Bank Abp, traded as HLSE:NDA FI, and its financing arm in Denmark...

First quarter earnings signal fresh focus on Fortum Oyj (HLSE:FORTUM) Fortum Oyj (HLSE:FORTUM) has drawn fresh attention after reporting first quarter 2026 earnings, with sales of €1,992 million, net income of €421 million, and basic EPS from continuing operations of €0.47. See our latest analysis for Fortum Oyj. Fortum Oyj’s share price has gained 17.5% year to date and the 1 year total shareholder return is 54.6%, suggesting investors have been reassessing the stock following stronger first...

The European market has shown resilience, with the pan-European STOXX Europe 600 Index ending the week slightly up amid ongoing geopolitical uncertainties and fluctuating oil prices. In this context, investors often seek opportunities in less conventional areas like penny stocks, which despite being an older term, continue to represent potential value in smaller or emerging companies. By identifying those with robust financials and growth potential, investors can uncover promising...

The European stock market has been navigating a complex landscape, with the pan-European STOXX Europe 600 Index ending the week largely unchanged amid ongoing geopolitical tensions and mixed economic signals. Despite these challenges, investors continue to seek opportunities in various corners of the market, including penny stocks. Although "penny stocks" is an outdated term, it remains relevant for identifying smaller or newer companies that can offer growth potential at lower price points...

Q1 2026 earnings snapshot GRK Infra Oyj (HLSE:GRK) has just posted its Q1 2026 scorecard, with the latest quarterly figures framed by trailing 12 month revenue of €872.3 million and basic EPS of €1.07, alongside a net profit margin of 4.9% over the last year. The company has seen revenue move from €728.6 million to €872.3 million and basic EPS rise from €0.93 to €1.07 over the trailing 12 month periods, while earnings grew 16.7% over the past year compared with a five year average annual EPS...

Q1 2026 snapshot: earnings in focus for NoHo Partners Oyj (HLSE:NOHO) NoHo Partners Oyj (HLSE:NOHO) enters Q1 2026 following a solid finish to 2025, with fourth quarter revenue of €101.8 million and basic EPS of €0.27 supported by net income of €5.7 million. Over recent quarters the company has seen revenue move from €96.6 million in Q4 2024 to €101.8 million in Q4 2025, while quarterly EPS shifted from €0.24 to €0.27. This sets up a results season where modest profit margins and relatively...

Nokia Oyj (HLSE:NOKIA) is back in focus after agreeing to sell its Fixed Wireless Access business to Inseego for about $20 million in stock and warrants, securing roughly a 7% equity stake. See our latest analysis for Nokia Oyj. That sale comes on top of a strong run in Nokia Oyj’s share price, with a 30 day share price return of 54.97% and a year to date gain of 106.19%. The 1 year total shareholder return of 164.62% signals powerful momentum rather than a short term spike. If you are...

As European markets navigate a complex landscape marked by stalled geopolitical negotiations and fluctuating energy prices, investors are keenly observing the performance of growth companies with strong insider ownership. In such an environment, stocks that boast high insider ownership can be appealing as they often indicate confidence from those closest to the business, potentially aligning with investor interests during uncertain times.

First quarter earnings put Metsä Board Oyj (HLSE:METSB) under closer scrutiny Metsä Board Oyj (HLSE:METSB) has drawn renewed attention after first quarter 2026 results showed sales of €393.7 million compared with €480.8 million a year earlier, with net loss widening to €16.7 million and basic loss per share at €0.04. See our latest analysis for Metsä Board Oyj. Despite the weak first quarter, Metsä Board Oyj’s share price shows mixed momentum, with a 12.36% 90 day share price return...

Sampo Oyj (HLSE:SAMPO) held its AGM on 22 April 2026, approving a €0.36 per share dividend for 2025. This decision puts income potential and capital allocation in focus for shareholders. See our latest analysis for Sampo Oyj. Despite the AGM decisions, Sampo Oyj’s share price has eased in recent months, with a 30 day share price return of a 4.37% decline and a year to date share price return of a 13.57% decline, while the 5 year total shareholder return of 65.29% points to stronger longer...

Konecranes (HLSE:KCR) shares are in focus after first quarter 2026 results showed lower sales and net income year on year, while management reaffirmed full year guidance and highlighted a new shipyard crane order from Meyer Turku. See our latest analysis for Konecranes. The share price reaction has been mixed, with a 7.21% 1 day share price return after the results, set against a 19.17% 90 day share price decline and a 46.47% 1 year total shareholder return that points to longer term...

Some Fiskars Oyj Abp ( HEL:FSKRS ) shareholders may be a little concerned to see that the Independent Non-Executive...

Huhtamäki Oyj (HLSE:HUH1V) stock has been reacting to Q1 2026 results, where the adjusted EBIT margin reached 10% and cash flow was strong, even as sales and net income were lower year on year. See our latest analysis for Huhtamäki Oyj. At a share price of €27.26, Huhtamäki Oyj has seen a 1-day share price return of 1.3% decline and a year to date share price return of 8.5% decline. The 1-year total shareholder return of 13.3% decline points to fading momentum despite the Q1 2026 margin...

The quarterly results for UPM-Kymmene Oyj ( HEL:UPM ) were released last week, making it a good time to revisit its...

What the latest earnings tell you about Hiab Oyj (HLSE:HIAB) Hiab Oyj (HLSE:HIAB) opened the quarter with earnings that showed lower sales and net income. This development can quickly influence sentiment if you hold or track the stock closely. See our latest analysis for Hiab Oyj. Despite the weaker quarter, Hiab Oyj’s share price has shown positive momentum recently, with a 1 month share price return of 20.83% and a year to date share price return of 2.24%, while the 1 year total shareholder...

Nokian Renkaat Oyj (HLSE:TYRES) shares are in focus after the company reported first quarter 2026 results showing higher sales and a smaller net loss, while also reiterating full year guidance for revenue growth and an 8% to 10% operating margin. See our latest analysis for Nokian Renkaat Oyj. The earnings update and reiterated 2026 guidance come after a 12.4% 1 month share price return and an 8.5% year to date share price gain, while the 1 year total shareholder return of 58.4% contrasts...

Earnings event and why it matters for Alma Media Oyj (HLSE:ALMA) Alma Media Oyj (HLSE:ALMA) has just reported first quarter 2026 results, with sales of €83.1 million and net income of €15.7 million, alongside higher basic and diluted earnings per share from continuing operations. See our latest analysis for Alma Media Oyj. The recent Q1 earnings release and board reorganisation came against a softer backdrop for the shares, with a 90 day share price return of a 9.42% decline and a year to...

Tieto Oyj (HLSE:TIETO) is back in focus after a reported 4 percentage point improvement in adjusted EBITA to 14.7%, coupled with fresh interim leadership appointments to support its ongoing transformation. See our latest analysis for Tieto Oyj. The share price reaction has been positive in the short term, with a 1-day share price return of 4.22% and 7-day share price return of 3.83% around the €19.0 level. However, the 1-year total shareholder return of 28.36% contrasts with weaker 3 and 5...

Terveystalo Oyj reported past first-quarter 2026 results showing sales of €308.2 million and net income of €17.2 million, both lower than a year earlier, with basic earnings per share from continuing operations falling to €0.14. Management also issued cautious guidance that profitability in the first half of 2026 will trail the first half of 2025, sharpening investor focus on how quickly the business can restore earnings momentum. With profitability in early 2026 expected to underperform...

Even though Verkkokauppa.com Oyj ( HEL:VERK ) posted strong earnings, investors appeared to be underwhelmed. Our...

Neste Oyj ( HEL:NESTE ) defied analyst predictions to release its first-quarter results, which were ahead of market...

Wondering if Nordea Bank Abp at €15.99 still offers value or if most of the opportunity is already priced in? This article walks through the key signals that matter for you. The share price has moved 2.0% over the last week and 5.6% over the last month, with a 37.9% return over 1 year and 105.8% over 3 years, while year to date it is down 2.3%. Recent coverage around Nordea Bank Abp has focused on its position within the wider European banking sector and how investors are weighing interest...

Why Kemira Oyj (HLSE:KEMIRA) is back on investors’ radar Kemira Oyj (HLSE:KEMIRA) has drawn fresh attention after first quarter 2026 results showed lower sales and net income than a year earlier, alongside new full year 2026 revenue guidance. See our latest analysis for Kemira Oyj. The 1-day share price return of 3.0% to €17.65 comes after a weaker first quarter and a new 2026 revenue range, while a 30-day share price decline of 8.6% contrasts with a 5-year total shareholder return of 56.7%...

Orion Oyj has started a Phase 1b/2 basket trial of ODM-212, an oral pan TEAD inhibitor. The study targets patients with advanced cancers, including mesothelioma, KRAS G12C mutated non small cell lung cancer, and pancreatic cancer. The trial initiation marks a new clinical step for Orion Oyj in oncology research. For investors watching HLSE:ORNBV, this new trial adds a fresh clinical asset to an already established pharma business. The share price is currently €68.7, with the stock up 3.1%...